Frazier Life Sciences
About
Frazier Life Sciences is a leading biotech investment firm with venture and public strategies, partnering with and building companies developing novel therapeutics. Based in Menlo Park, California, the firm manages over $3.3 billion in capital and focuses on early-stage private biopharmaceutical company creation and Series A investments. Since 2005, 61 portfolio companies have completed IPOs or M&As.
Key facts
- Website
- frazierls.com
- Type
- venture_capital
- Headquarters
- United States
- Portfolio companies
- 4
- Stages
- SeedSeries ASeries B
- Cheque size
- $80M to $137M
- Sector focus
- BiotechPharmaceuticalsLife Sciences
Recent investments
Test your Ahrefs DR
The backlink strength of a domain, on the Ahrefs 0 to 100 scale. About a minute.
Frequently asked
What companies has Frazier Life Sciences invested in?
Frazier Life Sciences has invested in Sidewinder Therapeutics, AirNexis Therapeutics, Aspen Neuroscience, Lexeo Therapeutics.
SEC filings, insider activity, nonprofit links and pay benchmarks for Frazier Life Sciences:


